Chainalysis

Phase A — Understand the business

Lens 1 · Company Overview

Chainalysis is the category-defining blockchain intelligence / crypto-compliance data platform — founded 2014 (NYC) by Michael Gronager, Jonathan Levin, and Jan Møller, originally to trace the ~650K BTC lost in the Mt. Gox collapse. Plain-terms business model: it ingests and labels public-blockchain data into a proprietary "knowledge graph" mapping on-chain addresses to real-world entities (exchanges, mixers, sanctioned wallets, illicit actors), then sells access to that graph as software + investigative services.

Product lines:

• Crypto Investigations (the original franchise) — tracing tools for law enforcement, tax agencies (IRS), regulators, DoD/FBI. The court-grade product.
• Crypto Risk / KYT ("Know Your Transaction") — real-time transaction screening / AML for exchanges and banks (the recurring-SaaS leg).
• Web3 Growth / advanced analytics — user analytics and BI for protocols (a smaller, differentiated leg competitors largely lack).
• Services — Investigations & Special Programs, Crypto Incident Response, plus a Training & Certification business (individual certs ~$399–$1.4K).

Customers. 1,500+ customers across ~70 countries. Named: Coinbase, Crypto.com, Gemini, Square/Block, Revolut, Barclays, BNY Mellon, Paysafe, BitGo, UNICEF. Government is the anchor: DoD, FBI, IRS; >70% of revenue is now public-sector. Federal contracts grew from ~$10M cumulative (2020) → ~$65M (Apr-2023).

Contract structure. Mix of multi-year government sole-source awards/renewals (sticky but budget-dependent, lumpy) and per-seat SaaS subscriptions (KYT screening, ~$10K+/seat entry). Revenue quality is bimodal: durable-but-lumpy gov + recurring-but-cyclical private. This contract DNA — gov-contractor-meets-SaaS — is the central valuation question (Lens 7/11). ``

Lens 2 · Supply Chain

A software/data firm, so the "supply chain" is a data-and-talent value chain, not a physical one. Map upstream → company → end customer:

Upstream inputs (data sources):

• Public blockchains themselves — Bitcoin, Ethereum, Tron, Solana, and 20+ chains; raw on-chain data is free/commoditized (no single-source dependency, but coverage breadth is competitive).
• Customer-contributed labels & subpoena returns — the proprietary edge: 500+ customers and government investigations feed entity attributions back into the graph (a data-network-effect input).
• Compute / cloud — standard hyperscaler infrastructure (cost line, not a chokepoint).
• Acquired data/IP — bolt-ons (Hexagate, Alterya) inject fraud/Web3-security data streams.

The company (transformation): clustering heuristics + entity attribution + (2026) AI agents convert raw chain data into investigable, court-defensible intelligence.

Downstream customers (end users):

• Government / law enforcement — DoD, FBI, IRS, foreign agencies (~70%+ of revenue).
• Crypto-native — Coinbase, Crypto.com, Gemini, Binance (via Alterya).
• TradFi / banks — Barclays, BNY Mellon, Revolut.
• Channel partner (new): Chainlink — KYT piped into Chainlink's on-chain Automated Compliance Engine (ACE), live Q2 2026.

Chokepoints / single-source dependencies: (1) the proprietary entity-attribution graph is the single most important, hardest-to-replicate input — built from a decade of investigations + the customer label feedback loop; (2) key-person/analyst expertise for court testimony (Daubert-grade experts are scarce); (3) government budget appropriations as a demand-side chokepoint (Lens 13). No physical single-source risk. Names present — lens passes.

Lens 3 · Competitive Advantages (moats)

Chainalysis is the gold-standard / category leader in blockchain investigations, with the strongest court record and the broadest government footprint. Moats, ranked by durability:

1. Data network effect (the real moat). A proprietary knowledge graph of ~1B+ mapped addresses and ~55K labeled entities, fed by 500+ customers and government subpoena returns. More customers → more labels → better attribution → more customers. This is genuinely hard to replicate cold and is the durable asset.
2. Court-defensibility / regulatory trust. Chainalysis is the only blockchain-analytics provider whose methodology survived a formal Daubert challenge (US v. Sterlingov, 2024; Judge Moss ruled the methods "reliable"). For a prosecutor, that is a near-decisive switching cost — you build a case on the tool that holds up in court.
3. Government switching costs / sole-source incumbency. Multi-year federal awards, certification programs, and entrenched workflows make rip-and-replace costly.
4. Brand / first-mover. Mt. Gox, Silk Road, FTX, Bitfinex case credibility — the name the press and agencies reach for.

Bargaining power. STRONG over crypto-native customers (compliance is non-optional; Chainalysis is the default). WEAKER over government — the buyer is a monopsony-ish set of agencies with budget cycles and competitive procurement (TRM has displaced it on some federal work — Lens 13). Over suppliers: high (raw chain data is free).

Moat fragility (don't oversell it): the moat is in attribution quality + court record, not the raw data. Competitors (Elliptic, TRM) are closing the coverage gap, and the heuristic methodology faces a live "junk science / not peer-reviewed" attack (Lens 10/13). The moat is real but narrowing, and it is concentrated in the one product (investigations) whose buyer is the most budget-exposed.

Lens 4 · Segments

No segment-level financials are disclosed (private; segments.csv is an empty scaffold). What can be reconstructed from web sources, all ``, low-confidence:

• By customer sector: Government/public sector >70% of revenue and rising; private sector the minority and the part that bled during the 2022–23 crypto winter (drove two layoff rounds).
• By product: Investigations (gov-anchored) is the largest and most defensible; KYT/Risk (private SaaS) the cyclical leg; Web3 Growth + the new fraud/security stack (Hexagate, Alterya) a growth tail.
• By geography: US-dominant (federal anchor) with international agency expansion across ~70 countries.

Trend & cause: the mix has shifted decisively toward government since 2022 — a deliberate pivot to stable, predictable revenue after private-sector attrition during the crypto downturn. Read both ways: de-risks revenue volatility, but increases single-buyer/budget concentration (the Lens 13 bear). The 2024–26 M&A (fraud/Web3 security) is an attempt to re-grow the private leg.

---

Phase B — Measure performance (+private overlay: Lens 5 → Funding & valuation; Lens 7 → Cap table & secondary marks; + Traction & unit economics)

Lens 5 · Funding & Valuation Trajectory (+private swap)

Total raised ~$536–538M across 11 rounds. Round history:

• Seed → Series E (2015–2021): consecutive ~$100M Series C/D/E in 2020–2021 (the crypto-bull capital wave); investors incl. Accel, Benchmark, Addition, Coatue, Paradigm, GIC.
• Series F — May 2022: $170M led by GIC (Singapore SWF); BNY Mellon, Emergence Capital + insiders (Accel, Blackstone, Dragoneer) participated. Valuation $8.6B — the peak. Implied multiple ~61x on ~$140M ARR.
• 2024 secondary (Haun Ventures): Haun "bought the dip" via secondary at an implied ~$2.5B valuation — ~70% below the $8.6B peak.
• "Series F" — Oct 7, 2025: a further round; Hercules Capital's first investment — a ~$9M senior-secured, non-dilutive venture-debt position maturing Oct-2028, earmarked for AI / data-advantage / new markets. This is a tell: raising a small slug of venture debt rather than a large priced equity round signals (a) they don't want to crystallize a down-round equity mark, and (b) they have enough cash to avoid dilutive equity — disciplined, but not a growth-at-all-costs posture.

Burn / cash: ~$200M cash on the balance sheet; ~$40M burned in H2-2023. Not yet profitable. At that burn pace, runway is multi-year — but the venture-debt raise + slower hiring says they are managing toward profitability/IPO-readiness, not torching cash.

Burn signals & discipline: two layoff rounds in 2023 (4.8% in Feb, ~15% in Oct, ~900→~750 heads); head-count back to ~790 (May-2026). The trajectory: peak-bubble raise → reset → disciplined rebuild. n/a — private, not disclosed for audited cash flow, exact runway, and current burn.

Lens 6 · Founder/Exec Voice & Narrative (sentiment proxy) (no earnings calls — +private)

No earnings calls exist; the proxy is founder interviews + the annual Links conference narrative.

Tone shift over time:

• 2020–22 (bull): "build trust in blockchains," hyper-growth, doubling revenue, land-grab.
• 2023 (reset): discipline, layoffs, "focus on compliance software and investigative tools" through the downturn.
• 2024–26 (Levin era): the consistent new line is "expand beyond investigations into prevention" — repeated across the Hexagate/Alterya M&A rationale and the 2026 AI-agents launch. Levin on IPO: "an IPO is something that may be considered in the future, but for now my focus is … growing Chainalysis and maximising our impact" — i.e., deliberately non-committal.

What they stopped saying: the 2021-era "$X billion valuation / hyper-growth" framing is gone; replaced by "discipline," "prevention," "AI," "auditable/deterministic." Sentiment read: sober, builder-mode, IPO-curious-but-patient — consistent with a company that took a valuation haircut and is rebuilding the equity story around AI + prevention before testing public markets.

Lens 7 · Cap Table, Secondary Marks & Comps (+private swap)

Syndicate quality (IPO-proximity tell): the cap table is tier-1 and crossover-heavy — Accel, Benchmark, Addition, Coatue, Paradigm, Ribbit, GIC (sovereign), BNY Mellon (strategic), Blackstone, Dragoneer, Emergence, Marc Benioff (angel), and Haun Ventures (2024 secondary). A GIC-led round + a strategic bank + crossover funds is exactly the syndicate you see ahead of an IPO. 46 investors total.

Secondary marks — the central valuation conflict (surfaced, not reconciled):

Interpretation: the 2024 Haun secondary at ~$2.5B was the trough mark; the 2026 PM share prices ($6.20–7.46) appear to show a partial recovery off that trough (share-price levels, not a stated post-money — I will not derive a 2026 valuation without a share count: n/a — share count not sourced). The honest read: somewhere between the $2.5B trough and the $8.6B peak, with the 2026 tape biased upward as crypto re-rated and the IPO window reopened. Do not anchor on $8.6B (a bubble print) or on $2.5B (a single distressed secondary).

Comps (RegTech/crypto-infra reference points — multiples are `` or n/a):

The framing that matters: Chainalysis trades the market between a 6–7x SaaS multiple and a lower gov-contractor multiple. On ~$250M+ ARR, 6–7x ≈ $1.5–1.75B; if the market grants a software premium for the data moat + AI story, higher. The $8.6B (~35x on 2024E ARR) is not defensible on current fundamentals — it was a 2022 multiple. The valuation reset is the thesis.

Lens 8 · Catalysts & Step-Changes (+private: funding/product events)

Events that re-rated the company (no public stock, so these are private-mark / narrative catalysts):

• May-2022: $8.6B Series F (peak).
• 2022–23: crypto winter + FTX collapse → private-sector attrition, two layoff rounds, valuation reset.
• 2024: Haun secondary at ~$2.5B (the markdown becomes public).
• Sep–Dec 2024: Gronager steps down; Levin (co-founder) becomes CEO; independent audit-committee chair (Paul Auvil) added — governance professionalization, an IPO-prep signal.
• 2024–25 M&A: Transposer, Nash, Hexagate (Web3 security), Alterya (~$150M, AI fraud detection — monitors >$8B/mo across Binance/Coinbase/Block) — the "prevention" pivot.
• 2025: CFO hire (Sebastien Giroux); "accelerated ARR growth across public and private" claimed; Hercules venture-debt round.
• Q1–Q2 2026: AI blockchain-intelligence agents launched at Links 2026 (pilot now, broad rollout summer-2026); Chainlink ACE integration live Q2-2026.
• Aug-2025: Tornado Cash / Roman Storm split verdict — a sector catalyst that cuts both ways for Chainalysis's forensic narrative (Lens 10/13).

What the pattern reveals: the value of this name keys off (a) the crypto cycle (private demand), (b) government budget appropriations, and (c) the credibility of its forensic methodology in court. The 2024–26 arc is a deliberate re-rating attempt: new CEO, audit chair, CFO, AI product, prevention M&A — assembling an IPO-ready equity story.

(+private) Lens 8.5 · Traction & Unit Economics

``, unaudited:

• ARR: ~$140M (2022) → $190M (2023, +35–36%) → ~$250M (2024E, ~+30%); "accelerated growth" claimed for 2025 — but no hard 2025 ARR figure is sourced (n/a — not disclosed).
• Revenue conflict (surfaced): Getlatka reports $87M "revenue" with a 791-person team (2025) — this conflicts with Sacra's $190M+ ARR and is almost certainly either (a) a stale/partial third-party scrape or (b) a different metric (recognized GAAP revenue vs ARR, or a sub-segment). I do not reconcile these; I flag the conflict. The Sacra ARR series is the higher-confidence read; the Getlatka figure is low-confidence.
• Customers: 350 (Nov-2020) → 750 (May-2022) → 1,500+ (2026); 150 customers at >$100K ARR by May-2022.
• Gross margin: n/a — not disclosed, but a data/SaaS business of this type structurally implies high (likely 70%+) software gross margins, diluted by the services/investigations labor.
• Profitability: not yet profitable; ~$200M cash, ~$40M H2-23 burn. NRR / churn: n/a — not disclosed.

---

Phase C — Judge people & books

Lens 9 · Management

Jonathan Levin — CEO (since Dec 3, 2024), co-founder, ex-Chief Strategy Officer (~a decade).

• Track record: co-built Chainalysis from the Mt. Gox-tracing origin into the category leader; ran strategy/commercial through the scale years. Promoted from within — continuity, deep institutional knowledge.
• Skin in the game: co-founder equity (material, undisclosed %).
• Capital allocation under his watch (the live test): aggressive M&A (Transposer, Nash, Hexagate, Alterya ~$150M) to pivot into prevention/fraud/Web3-security; disciplined financing (venture debt vs dilutive equity). Verdict pending — the prevention pivot is strategically coherent (extend the moat beyond the budget-exposed gov-investigations leg) but unproven on ROI; integration risk is real.
• Archetype: founder-operator, builder-mode, IPO-patient.

Michael Gronager — co-founder, former CEO (stepped down Sep/Dec 2024). Built the company through scale; orderly transition to a co-founder (not an outside hire) is a positive governance signal, not a crisis exit.

Sebastien Giroux — CFO (2025). Hired to steward ARR growth and (read-through) prepare financial infrastructure for an eventual IPO.

Paul Auvil — independent director, audit-committee chair (Dec-2024). Veteran tech/finance operator; adding an independent audit chair is a textbook pre-IPO governance step.

Red flags (management): none acute. Watch: (1) two layoff rounds in 2023 (execution under stress — handled, but a scar); (2) M&A-heavy strategy under a first-time CEO (integration + capital-allocation risk); (3) the valuation round-trip ($8.6B→$2.5B) happened on this team's watch (mostly macro, but it sets the IPO anchor problem). Insider-ownership detail: n/a — private, not disclosed (no insider-transactions.csv).

Lens 10 · Forensic Red Flags + Regulatory

Accounting forensics: not applicable in the usual sense — no audited financials, no 10-K, no segment reporting to scrutinize. The standard income-statement / balance-sheet / cash-flow red-flag battery cannot be run on a private company with no disclosures. What can be said: the ARR vs revenue conflict ($190M+ ARR vs $87M third-party "revenue," Lens 8.5) is itself a data-quality flag — private metrics are self-reported/unaudited and should be discounted. SBC, revenue-recognition, and goodwill-from-acquisitions (Hexagate/Alterya) are all plausible future-IPO scrutiny points but unobservable today.

The real "forensic" risk here is the product's own forensics, not the company's accounting — and it is material:

Regulatory / legal findings:

• SEC (EDGAR LR + AAER): none — Chainalysis is private with no CIK; no EDGAR enforcement is possible.
• Non-SEC web search ("Chainalysis" enforcement/litigation): no enforcement against Chainalysis surfaced. The legal exposure is the opposite vector — Chainalysis's methodology is repeatedly attacked in court:
• US v. Sterlingov (Bitcoin Fog, 2024): Chainalysis methodology survived a Daubert challenge — Judge Moss ruled it "the product of reliable principles and methods". This is the single most important legal fact for the franchise — it is the only blockchain-analytics tool with a federal admissibility ruling.
• Defense-bar attacks: critics (and some defense lawyers) label the heuristics "junk science" — not peer-reviewed, no published false-positive rate; a prosecution witness's claim of "0 false positives" in Bitcoin Fog is criticized as implausible. Bitcoin Magazine ran a "Theranos of blockchain forensics" piece.
• Tornado Cash / Roman Storm (Aug-2025): split verdict — guilty on unlicensed money-transmission, jury deadlocked on the money-laundering and sanctions counts; the defense explicitly questioned the reliability of third-party blockchain analysis incl. Chainalysis.
• Chainalysis's rebuttal: independent study cited true-positive rates up to ~94.85% / false-positive ~0.01%; deterministic clustering (same inputs → same outputs).
• Net: "No regulatory or enforcement action against Chainalysis — verified via SEC EDGAR EFTS (no CIK, 0 LR/AAER) and web search as of 2026-06-30. The material legal exposure is the courtroom admissibility of its methodology (Daubert-survived in Sterlingov 2024, but actively contested), not enforcement against the company."

(carry) Privacy / civil-liberties exposure

Recurring criticism over law-enforcement/ICE data use; only ~10% of surveyed users express confidence in industry data privacy. Reputational/regulatory tail, not a P&L item today.

---

Phase D — Project & stress-test (+private: Lens 11 → IPO-readiness)

Lens 11 · IPO-Readiness & Path-to-Tradeable (+private swap — no EPS)

No research/private-watch.json entry exists for Chainalysis — this dossier should seed one.

Readiness assessment (my synthesis, ``):

• Stage: late-stage / IPO-eligible — scaled ($250M+ ARR), category-leading, crossover-and-sovereign-backed, governance professionalized (independent audit chair, new CFO).
• IPO-readiness: MEDIUM-HIGH on capability, LOW-MEDIUM on stated intent. What's done: independent board/audit committee (Dec-2024), CFO (2025), CEO succession (2024), AI product story (2026). What's missing/unlocking: no S-1, no bankers, no range, no date; explicitly "no indication of going public in 2026"; Levin deliberately non-committal. Bitwise/Bitwise-type lists name it a 2026-IPO candidate.
• Catalysts that unlock an S-1: (1) a clean return to ARR growth re-acceleration + a credible path to profitability (the venture-debt + discipline posture suggests they're engineering this); (2) a friendly crypto-IPO tape — Circle's 2026 listing and Coinbase's re-rating reopened the window; a successful crypto-infra IPO cohort pulls Chainalysis forward; (3) proof the AI-agents + prevention pivot re-grows the private leg (de-risks the gov-concentration story the public market will dislike).
• Estimated window: 2026 plausible but not committed; 2027 more likely for a priced IPO, contingent on the above.
• Tradeable today: yes, via secondaries (Forge ~$6.20, NPM ~$7.46, Notice.co ~$6.2–6.4 per share, mid-2026) — accredited-only, illiquid.

Per skill contract: this dossier should write back a private-watch.json entry (stage: late-stage, ipo_readiness: medium-high, catalyst: ARR re-accel + crypto-IPO window + prevention-pivot proof, dossier: companies/chainalysis/deep-dive-2026-06-30.md). Not executed in this unattended --watchlist run (no write-back to research/ config files per wave boundaries) — flag for Connor.

No EPS forecast / no forecast.ts create — private, pre-IPO, no EPS to project, and forecast logging is skipped in the watchlist loop per skill.

Lens 12 · Bull vs Bear

Bull case. Chainalysis is the pick-and-shovel monopoly of crypto compliance — the default tool of governments and exchanges, with a genuine data-network-effect moat (1B+ addresses, decade of investigations) and the only court-admissibility ruling in the category. As crypto re-institutionalizes (ETFs, stablecoin legislation, Circle public, Coinbase profitable), AML/compliance demand is secular and non-optional — every regulated on-ramp needs KYT. The 2024–26 transformation (AI agents, Chainlink ACE, prevention M&A) extends the franchise beyond budget-exposed gov-investigations into recurring private-sector prevention, the higher-multiple revenue. Governance is IPO-ready. At 6–7x ARR ($1.5–1.75B) vs the $8.6B peak, you'd be buying a category monopoly at a gov-contractor multiple with a software-moat upside option — the valuation reset is the opportunity. Earnings surprise: a clean profitability inflection + ARR re-acceleration into a 2026–27 crypto-IPO window.

Bear case (2–3 permanent-impairment risks).

1. Methodology de-rated by the courts. If a higher court (or a string of acquittals like the Tornado Cash deadlock) erodes Daubert admissibility / brands the heuristics "junk science," the investigations franchise — the gov-anchored 70%+ of revenue — structurally impairs. This is the genuine permanent risk, not a cyclical one.
2. Government concentration meets budget/DOGE risk. >70% gov revenue is "stable" until appropriations turn — DOGE terminated ~$61B of contracts; lumpy, budget-dependent, competitively re-procured revenue is exactly what public-market investors discount. TRM has already taken federal share.
3. Commoditization / competitive compression. Elliptic (99% coverage claim) and TRM (AI-first, unicorn) are closing the gap; most large exchanges run two providers; AI lowers the barrier to "good-enough" attribution. The moat narrows; pricing power erodes.

Pre-mortem (18 months out, thesis broke): the AI-agents launch under-delivered (or commoditized the very investigative work it sells), a court ruling dented the forensic brand, a federal budget cycle cut a marquee contract, and the IPO got pulled into a cold crypto tape — the company re-rates down toward the $2.5B trough, not up.

Multiples too high? $8.6B is indefensible (~35x 2024E ARR). ~6–7x ARR is fair-to-cheap if growth re-accelerates and the methodology risk stays contained. The contrarian view the market is refusing to see: this is increasingly a government-IT/RegTech contractor, not a hyper-growth crypto-software company — and it should be valued like one (single-digit ARR multiple), which is lower than crypto bulls hope but higher than the distressed $2.5B secondary implied. The mispricing cuts both ways.

Lens 13 · Devil's Advocate (short-seller)

I am dismantling the bull case.

• Revenue concentration is the kill-shot. >70% from government, anchored in investigations — a single product, sold to budget-cyclical, competitively-procured buyers, in a DOGE-cutting environment. Lose two marquee federal renewals and the growth story collapses. TRM already proved the gov buyer is contestable.
• The moat is a methodology that defense lawyers call junk science. The entire investigations franchise rests on heuristics that are not peer-reviewed and have no published false-positive rate; Chainalysis's own witness claimed "0 false positives," which is not credible. One adverse appellate ruling and the court-defensibility moat — the thing customers actually pay for — cracks. Tornado Cash already showed juries deadlocking where the chain-analysis narrative was contested.
• AI is a double-edged sword. The 2026 AI-agents pitch is "automate investigations" — but if AI makes attribution cheap, it commoditizes Chainalysis's own core service and invites well-capitalized entrants (and customers' in-house teams) to replicate "good enough."
• The valuation round-trip is a flashing light. $8.6B → $2.5B secondary in two years; the latest capital was venture debt, not a priced up-round — because a priced round would have crystallized a brutal down-mark. The PM share-price "recovery" (Forge/NPM) is thin, illiquid accredited-market data, not a real clearing price.
• Worst capital-allocation risk: an M&A-heavy strategy (Hexagate, Alterya $150M) under a first-time CEO, paying private-market prices into integrations that may not re-grow the private leg fast enough to offset gov lumpiness.
• Assumptions that must hold for today's secondary price: ARR keeps compounding ~30%; methodology stays court-admissible; gov budgets hold; the prevention pivot works; a crypto-IPO window stays open. If growth disappoints 20–30%, a single-digit ARR multiple on a decelerating, gov-concentrated, litigation-exposed base puts fair value back toward $1.5–2.0B — i.e., the secondary "recovery" reverses.
• Single permanent-impairment scenario (most plausible): an appellate court limits or excludes Chainalysis-style heuristic attribution as expert evidence → the investigations moat and the gov franchise both impair simultaneously. Plausibility: low-to-moderate, but non-trivial and asymmetric.

Lens 14 · Management Questions (ordered by information value)

1. What is current (2025/2026) ARR, the YoY growth rate, and net revenue retention — and how much of ARR is government vs private, and recurring vs services?
2. What share of revenue is the single largest customer / the top-5 government agencies, and what is the renewal/re-compete schedule on those contracts over the next 24 months?
3. What is your path to GAAP profitability — target date, and what operating-margin level does the model reach at scale?
4. How exposed is your government revenue to appropriations/DOGE-style cuts, and which awards are sole-source vs competitively bid?
5. On methodology: do you publish a peer-reviewed false-positive/false-negative rate, and what is your plan if an appellate court narrows the admissibility you won in Sterlingov?
6. How do the AI agents change your own unit economics — do they expand margins, or do they commoditize the investigative work you currently bill for?
7. What is the integration status and revenue contribution of Hexagate and Alterya, and what ROIC do you underwrite on M&A?
8. What is current cash, monthly burn, and runway — and why raise venture debt (Hercules) rather than priced equity?
9. What are the concrete milestones and the realistic window for an S-1, and what has to be true first?
10. How fast is the private-sector (KYT/prevention) leg re-growing, and can it structurally reduce government concentration below 50%?
11. Who is your most dangerous competitor — Elliptic on coverage or TRM on AI/federal — and where are you losing deals?
12. How defensible is the data-network-effect moat as AI lowers the cost of attribution for new entrants and in-house teams?
13. What is the Chainlink ACE / on-chain compliance opportunity worth, and is it additive revenue or a low-margin channel?
14. How do you manage the civil-liberties/privacy and surveillance-reputational risk without losing government demand?
15. What is the right comparable for valuing Chainalysis — high-multiple vertical SaaS, or single-digit-multiple government-IT/RegTech — and why?

---